NCT04659226View on ClinicalTrials.gov

MicroRNA Profile and Erenumab Treatment

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

July 1, 2021

Primary Completion Date

December 31, 2022

Study Completion Date

April 30, 2023

Conditions
Migraine
Interventions
GENETIC

Blood sampling for microRNA testing

Blood samples will be collected and analyzed for the microRNA profile by means of microfluidic cards

Trial Locations (1)

67100

University of L'Aquila, L’Aquila

Sponsors

Collaborators (1)

Novartis
All Listed Sponsors
collaborator

Novartis

INDUSTRY

lead

University of L'Aquila

OTHER